KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Equity Ratio (2018 - 2025)

Historic Equity Ratio for BioNTech SE (BNTX) over the last 4 years, with Q4 2021 value amounting to 0.75.

  • BioNTech SE's Equity Ratio rose 2698.4% to 0.75 in Q4 2021 from the same period last year, while for Dec 2021 it was 0.75, marking a year-over-year increase of 2698.4%. This contributed to the annual value of 0.75 for FY2021, which is 2698.4% up from last year.
  • As of Q4 2021, BioNTech SE's Equity Ratio stood at 0.75, which was up 2698.4% from 0.59 recorded in Q4 2020.
  • BioNTech SE's Equity Ratio's 5-year high stood at 0.75 during Q4 2021, with a 5-year trough of 0.41 in Q4 2018.
  • In the last 4 years, BioNTech SE's Equity Ratio had a median value of 0.61 in 2019 and averaged 0.59.
  • As far as peak fluctuations go, BioNTech SE's Equity Ratio surged by 5131.05% in 2019, and later crashed by 437.12% in 2020.
  • BioNTech SE's Equity Ratio (Quarter) stood at 0.41 in 2018, then soared by 51.31% to 0.62 in 2019, then decreased by 4.37% to 0.59 in 2020, then rose by 26.98% to 0.75 in 2021.
  • Its last three reported values are 0.75 in Q4 2021, 0.59 for Q4 2020, and 0.62 during Q4 2019.